The Hematology Analyzers & Reagents Market report provides a basic overview of the market including definitions, classifications, applications and industry chain structure. The Hematology Analyzers & Reagents Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.
Key Players Analysis:
- Clinical Diagnostic Solutions, Inc.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Danaher
- BIO-RAD LABORATORIES INC.
- Abbott
- Diatron
- ERBA Diagnostics Inc.
- EKF Diagnostics
- HORIBA Medical
- Biosystems S.A.
The report covers key developments in the Hematology Analyzers & Reagents Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Hematology Analyzers & Reagents Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Hematology Analyzers & Reagents Market in the global market. Below mentioned is the list of few companies engaged in the Hematology Analyzers & Reagents Market.
Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behavior & the growth of the market as well as industries.
MARKET SEGMENTATION
The global hematology analyzers & reagents market, based on product and service, is segmented into hematology products & services, hemostasis products & services, and immunohematology products & services. The hematology products and services segment is further segmented into instruments, reagents & consumables, and services. Similarly, the hemostasis products & services segment is further segmented into instruments, reagents & consumables, and services. The immunohematology products & services segment of the hematology analyzers & reagents market is also further segmented into instruments, reagents & consumables, and services. Out of the three segments of the hematology analyzers & reagents market based on product and service, the hematology products and services segment held the largest market share in 2019, encompassing almost half of the market share and is anticipated to register the highest CAGR in the market during the forecast period, as the product is used most commonly in practice. This is due to the diverse testing volumes of the analyzers that help deliver accurate results. Moreover, these instruments are most frequently used in medical laboratories to detect proteins or enzymes and count blood cells to help diagnose illness or genetic defects.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Hematology Analyzers & Reagents Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hematology Analyzers & Reagents Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person : Sameer Joshi .
Phone : +1-646-491-9876
E-mail : [email protected]
The global Hematology Analyzers And Reagents Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the hematology analyzers and reagents market include Abbott, Bio-Rad Laboratories, Horiba, Siemens, Sysmex, BioSystems , Boule, Danaher, Diatron, Drew Scientific, EKF Diagnostics, Mindray, Nihon Kohden, Ortho Clinical Diagnostics, Roche, Beckman Coulter, Bayer , Cholestech , Heska , Drucker, Instrumentation Laboratory, Abaxis.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Hematology Analyzers And Reagents Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/hematology-analyzers-and-reagents-market/download-sampleMarket DynamicsThe global hematology analyzers and reagents market is forecasted to thrive with the rising prevalence of patients suffering from blood disorders, the growing burden of target diseases, and increasing blood transfusions worldwide.
Hematology analyzer manufacturers are increasingly investing in analyzers' research and development with microfluidics technology that uses low volumes of sample and reagents.
Hematology analyzers deliver high-speed results, accurate results with better cell differentiation, and reduce or eliminate the need for manual intervention.
The increasing incidence of blood disorders and the growth in the number of blood donation are the major factors driving the growth of the global hematology analyzers and reagents market.
Technological advancements in hematology analyzers and reagents and the integration of flow cytometry techniques with hematology analyzers are also expected to support the growth of this market during the forecast period.The report Hematology Analyzers and Reagents Market is projected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9% during the forecast period.Ask for PDF Brochure: –https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146Market Segmentation: -On the basis of products & services, the hematology reagents market is classified into hematology, hemostasis, and immunohematology products & services.
The hematology products & services segment is projected to grow at the highest growth rate during the forecast period.By end user, the hematology analyzers market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research & academic institutes.
In 2019, the commercial service providers segment accounted for the largest share of the market due to factors such as the increasing awareness about hematology testing, shift from manual testing to automated testing, and the competitive benefits offered by these providers as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management of sample collection).Recent Developments: -In February 2018, Sysmex entered into an agreement with McKesson to distribute Sysmex’s XW-100 automated hematology analyzers in the US.In September 2017, Sysmex entered into an agreement with Mongolia’s Ministry of Health to provide technological, scientific, and external quality assessment support in the field of blood morphology to raise the accuracy of testing in the Mongolian region.Sysmex expanded its direct sales network in the Republic of Ghana (Africa) to reinforce its hematology sales and service structure in the African market.In July 2017, Sysmex launched XN-9100, XN-3100, XN-1500, and SP-50 (an automated hematology slide preparation unit).In July 2017, Sysmex launched the XN-L automated hematology analyzers in the US.Regional Analysis: -North America accounted for the largest share of the market in 2019.
This can be attributed to the rising incidence of patients suffering from blood disorders, the growing prevalence of target diseases, and the rising demand for blood transfusions in the region.Request for Sample Pages : – https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146Top key Players:-The major players in the global hematology reagents market are Sysmex Corporation (Japan), Abbott Laboratories (US), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland).
